|
Reference
|
|
*** (1994) Harmonised Tripartite Guidline. u: Third International Conference on Harmonisation of Technical Requirmants for the Registration of Pharmaceuticals for Human Use (ICH), Text on Validation of Analytical Procedures, London
|
|
*** (2011) European Pharmacopoeia 7.0. Strasbourg, France: European Directorate for the Quality of Medicines & HealthCare (EDQM) - Council of Europe, Vol 1. 01
|
[ CR ] [ EČ ][ GS ]
|
Chen, W., Gu, B., Wang, H., Pan, J., Lu, W., Hou, H. (2008) Development and evaluation of novel itraconazole-loaded intravenous nanoparticles. International Journal of Pharmaceutics, 362(1-2): 133-140
|
[ CR ] [ PM ] [ EČ ][ 1 ][ GS ]
|
Dejaegher, B., Dumarey, M., Capron, X., Bloomfield, M.S., Vander, H.Y. (2007) Comparison of Plackett-Burman and supersaturated designs in robustness testing. Analytica chimica acta, 595(1-2): 59-71
|
[ CR ] [ PM ] [ EČ ][ GS ]
|
Dumarey, M., Sneyers, R., Janssens, W., Somers, I., Vander, H.Y. (2009) Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase. Analytica chimica acta, 656(1-2): 85-92
|
[ CR ] [ PM ] [ EČ ][ GS ]
|
Ekiert, R.J., Krzek, J., Talik, P. (2010) Chromatographic and electrophoretic techniques used in the analysis of triazole antifungal agents-a review. Talanta, 82(4): 1090-100
|
[ CR ] [ PM ] [ EČ ][ GS ]
|
Gagliardi, L., de Orsi, D., Chimenti, P., Porra', R., Tonelli, D. (2003) HPLC determination of imidazole antimycotis in antidandruff cosmetic products. Analytical sciences, 19(8): 1195-7
|
[ CR ] [ EČ ][ GS ]
|
Koks, C.H., Sparidans, R.W., Lucassen, G., Crommentuyn, K.M., Beijnen, J.H. (2002) Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients. Journal of Chromatography B, 767(1): 103-110
|
[ CR ] [ EČ ][ 2 ][ GS ]
|
Lundstedt, T., Seifert, E., Abramo, L., Thelin, B., Nyström, Å., Pettersen, J., Bergman, R. (1998) Experimental design and optimization. Chemometrics and Intelligent Laboratory Systems, 42(1-2): 3-40
|
[ CR ] [ EČ ] [ WOS ][ 1 ][ GS ]
|
Mašković, M., Jančić-Stojanović, B., Malenović, A., Ivanović, D., Medenica, M. (2010) Assessment of liquid chromatographic method robustness by use of Plackett-Burman design. Acta Chromatographica, 22(2): 281-296
|
[ EČ ][ GS ]
|
Parikh, S.K., Patel, A.D., Dave, J.B., Patel, C.N., Sen, D.J. (2011) Development and validation of UV spectrophotometric method for estimation of itraconazole bulk drug and pharmaceutical formulation. International Journal of Drug Development & Research, 3(2), 324-328
|
[ CR ] [ PM ] [ EČ ][ GS ]
|
Srivatsan, V., Dasgupta, A.K., Kale, P., Datla, R.R., Soni, D., Patel, M., Patel, R., Mavadhiya, C. (2004) Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high-performance liquid chromatography. Journal of chromatography. A, 1031(1-2): 307-13
|
[ CR ] [ PM ] [ EČ ][ 3 ][ GS ]
|
Vander, H.Y., Nijhuis, A., Smeyers-Verbeke, J., Vandeginste, B.G., Massart, D.L. (2001) Guidance for robustness/ruggedness tests in method validation. Journal of pharmaceutical and biomedical analysis, 24(5-6): 723-53
|
[ CR ] [ EČ ][ GS ]
|
Vander, H.Y., Jimidar, M., Hund, E., Niemeijer, N., Peeters, R., Smeyers-Verbeke, J., Massart, D.L., Hoogmartens, J. (1999) Determination of system suitability limits with a robustness test. Journal of Chromatography A, 845(1-2): 145-154
|
[ CR ] [ EČ ][ GS ]
|
Wong, J.W., Nisar, U., Yuen, K.H. (2003) Liquid chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies. Journal of Chromatography B, 798(2): 355-360
|
|
|
|